The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Buleyko A.A.

Rostov State Medical University, Rostov, Russia;
Aksay Branch of Rostov region neuropsychiatric clinic, Rostov Region, Russia

Soldatkin V.A.

GBOU VPO "Rostovskiĭ gosudarstvennyĭ meditsinskiĭ universitet" Minzdrava Rossii, Rostov-na-Donu

Murina I.V.

Rostov State Medical University, Rostov, Russia

Ruban D.A.

Aksay Branch of Rostov region neuropsychiatric clinic, Rostov Region, Russia

Simak O.Ya.

Rostov State Medical University, Rostov, Russia

Krysenko P.B.

Rostov State Medical University of the Ministry of Healthcare of the Russian Federation, Rostov, Russia

Kryuchkova M.N.

Rostov State Medical University of the Ministry of Healthcare of the Russian Federation, Rostov, Russia

Does alcohol influence the cognitive functions of schizophrenic patients?

Authors:

Buleyko A.A., Soldatkin V.A., Murina I.V., Ruban D.A., Simak O.Ya., Krysenko P.B., Kryuchkova M.N.

More about the authors

Read: 2122 times


To cite this article:

Buleyko AA, Soldatkin VA, Murina IV, Ruban DA, Simak OYa, Krysenko PB, Kryuchkova MN. Does alcohol influence the cognitive functions of schizophrenic patients? S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(7):14‑19. (In Russ.)
https://doi.org/10.17116/jnevro201911907114

Recommended articles:
PANSS six-factor model. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):28-34
Clinical and immu­nological rela­tionships in patients with early schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):35-42
Clinical and psychopathological features of treatment-resistant schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):43-50
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Possibilities of vibroacoustic therapy application in patients with chro­nic bronchopulmonary pathology. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(1):12-18
Effi­cacy of dupi­lumab application in bullous pemphigoid proceeding in presence of bronchial asthma. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):204-209

References:

  1. Santos AP, Teixeira JA. Medical comorbidity in schizophrenia. European Psychiatry. 2017;41:276. https://doi.org/10.1016/j.eurpsy.2017.02.114
  2. Jorandby-Quinones L, Edens E, Rosenheck RA. Co-occurring Substance and Mental Health Disorders. Military and Veteran Mental Health. NY: Springer; 2018. https://doi.org/10.1007/978-1-4939-7438-2_20
  3. Uher R, Zwicker A. Etiology in psychiatry: embracing the reality of poly-gene-environmental causation of mental illness. World Psychiatry. 2017;16(2):121-129. https://doi.org/10.1002/wps.20436
  4. Oluwoye OP, Hirchak K, Leickly E, Skalisky J, McPherson S, Srebnik D, Roll JM, Ries RK, McDonnell MG. Interaction between pre-treatment drug use and heterogeneity of psychiatric diagnosis predicts outcomes in outpatients with co-occurring disorders. Psychiatry Research. 2018;260:233-235. https://doi.org/10.1016/j.psychres.2017.11.070
  5. Alderson HL, Semple DM, Blayney C, Queirazza F, Chekuri V, Lawrie SM. Risk of transition to schizophrenia following first admission with substanceinduced psychotic disorder: a population-based longitudinal cohort study. Psychol Med. 2017;3:1-8. https://doi.org/10.1017/S0033291717001118
  6. Balhara YP, Kuppili PP, Gupta R. Neurobiology of comorbid substance use disorders and psychiatric disorders: current state of evidence. J Addict Nurs. 2017;28(1):11-26. https://doi.org/10.1097/JAN.0000000000000155
  7. Smulevich AB. Schizophrenia or a group of endogenous diseases? The past and the present. Zhurnal Nevrologii i Psikhiatrii im. S.S. Korsakova. 2015;115(8):4-12. (In Russ.) https://doi.org/10.17116/jnevro2015115814-12
  8. Neznamov GG, Syunyakov TS, Nefedyeva IO. New perspectives of pharmacological correction of cognitive disorders in schizophrenia. Jeksperimental’naja i Klinicheskaja Farmakologija. 2018;81(5):174-175. (In Russ.)
  9. Nemkova TN, Goffman AG. Alcohol delirium arising in a patient suffering from paranoid schizophrenia. Nezavisimyj Psihiatricheskij Zhurnal. 2017;2:81-84. (In Russ.)
  10. Gofman AG, Ponizovsky PA. Comorbidity of mental disorders with alcohol addiction. Voprosy Narkologii. 2018;2:102-113. (In Russ.)
  11. Oskolkova SN. Addictive behavior in elderly patients with schizophrenia. Voprosy Narkologii. 2018;6(166):76-77. (In Russ.)
  12. Gouzoulis-Mayfrank E, Walter M. Schizophrenia and addiction. In: Geert Dom Franz Moggi (Editors). Co-occurring addictive and psychiatric disorders. A practice-based handbook from a european perspective. Berlin: Springer; 2015.
  13. Buleyko AA, Soldatkin VA. The problem of comorbidity of schizophrenia and alcohol abuse. Psikhicheskoe Zdorovie. 2018;8:74-82. (In Russ.) https://doi.org/10.25557/2074-014X.2018.08.74-82
  14. Khokhar JY, Dwiel LL, Henricks AM, Doucette WT, Green AI. The link between schizophrenia and substance use disorder: A unifying hypothesis. Schizophrenia Research. 2018;194:78-85.
  15. Dorofeikova MV, Petrova NN. Cognitive dysfunction in schizophrenia and its treatment. Sovremennaya Terapiya Psikhicheskikh Rasstroystv. 2015;1:2-10. (In Russ.)
  16. Koshkina E, Spektor S, Sencov V, Bogdanov S. Health, social and economic consequences of drug and alcohol addiction. M.: Litres; 2019. (In Russ.)
  17. Bryun EA, Koshkina EA, Nadezhdin AV, Kolgashkin AYu, Sokoltchik EI, Bedina IA. Prevention and treatment of drug and alcohol addiction in Scandinavian countries. Narkologiya. 2017;16(4):11-21. (In Russ.)
  18. Bukhanovsky AO, Soldatkin VA, Baranova IV. Factors predisposing to pathological gambling. Zhurnal Nevrologii I Pskhiatrii im. S.S. Korsakova. 2008;108(10):20-26. (In Russ.)
  19. Ergün S, Yanartas O, Kandemir G, Yaman A, Yildiz M, Haklar G, Sayar K. The relationship between psychopathology and cognitive functions with cytokines in clinically stable patients with schizophrenia. Psychiatry and Clinical Psychopharmacology. 2018;28(1):66-72. https://doi.org/10.1080/24750573.2017.1380920
  20. Psychiatry. National leadership. Edited by Aleksandrovskiy Yu.A., Neznanov N.G. 2nd edition. M.: GEOTAR-Media; 2018. (In Russ.)
  21. Pikirenia VI, Kopytov AV. The impact of psychoactive substances on cognitive functions. Meditsinskiy Zhurnal Belorusskogo Gosudarstvennogo Meditsinskogo Universiteta. 2017;1:14-24. (In Russ.)
  22. Stepanova AV, Kotsyubinskiy AP, Isaeva ER, Lebedeva GG. Analysis of cognitive dysfunctions in patients with paranoid schizophrenia depending on the severity of psychopathological symptoms. XVI S’yezd psikhiatrov Rossii. Vserossiyskaya nauchno-prakticheskaya konferentsiya s mezhdunarodnym uchastiyem. Psikhiatriya na etapakh reform: problemy i perspektivy. 2015;330. (In Russ.)
  23. Goldstein G, Allen DN, Sanders RD. Sensory-perception dysfunction in patients with schizophrenia and comorbid alcoholism. Journal of clinical and experimental neuropsychology. 2002;24(8):1010-1016.
  24. Manning V, Betteridge S, Wanigaratne S, Best D, Strang J, Gossop M. Cognitive impairment in dual diagnosis inpatients with schizophrenia and alcohol use disorder. Schizophrenia research. 2009;114(1):98-104.
  25. Nazzaro DM. Neuropsychological differences between patients diagnosed with schizophrenia and comorbid schizophrenia and alcohol dependence. 2003;2596-2596.
  26. Potvin S, Stavro K, Pelletier J. Paradoxical cognitive capacities in dual diagnosis schizophrenia: the quest for explanatory factors. Journal of Dual Diagnosis. 2012;8(1):35-47.
  27. Litvintsev SV, Kolchev SA, Ershov BB. Neurocognitive deficits in schizophrenia patients in combination with alcohol dependence. Sotsial’naya i Klinicheskaya Psikhiatriya. 2012;22(1):28-31. (In Russ.)
  28. Adan A, Capella M, Prat G, Forero D, Lopez-Vera S, Navarro JF. Executive functioning in men with schizophrenia and substance use disorders influence of lifetime suicide attempts. PloS one. 2017;12(1):e0169943.
  29. Liraud F, Verdoux H. Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders. L’Encephale. 2002;28(2):160-168.
  30. Nixon SJ, Hallford HG, Tivis RD. Neurocognitive function in alcoholic, schizophrenic, and dually diagnosed patients. Psychiatry Research. 1996;64(1):35-45.
  31. Joyal CC, Halle P, Lapierre D, Hodgins S. Drug abuse and/or dependence and better neuropsychological performance in patients with schizophrenia. Schizophrenia Research. 2003;63(3):297-299.
  32. Eryshev OF, Tulskaya TYu, Rybakova KV, Eroshin SP. Clinical symptoms of schizotypal personality disorder comorbid with alcohol dependence. Obozreniye Psikhiatrii i Meditsinskoy Psikhologii im. V.M. Bekhtereva. 2012;4:32. (In Russ.)
  33. Hofman AG, Schlemina IV, Loshakov ES, Malkov KD. Sluggish schizophrenia (schizotypical disorder) combined with alcohol addiction. Nezavisimyy Psikhiatricheskiy Zhurnal. 2009;1:21-25 (In Russ.)
  34. Shlemina IV. Clinical features and therapy of schizotypal disorder and comorbid alcohol dependence Psikhicheskoe Zdorovie. 2009;7(5):39-46 (In Russ.)
  35. Cherednikova TV. Differences of thought disturbances in schizophrenia and organic brain diseases. Sibirskij Vestnik Psihiatrii i Narkologii. 2014;2:22-25. (In Russ.)
  36. Luriya AR. Zauchivaniye 10 slov. Al’manakh psikhologicheskikh testov. M.: KSP; 1996. (In Russ.)
  37. Burlachuk LF. Slovar’-spravochnik po psikhodiagnostike. 3-ye izd. Izdatel’skiy dom «Piter»; 2007. (In Russ.)
  38. Benton AL. The visual retention test as a Constructional praxis task. Confinia Newrologica. 1962;22(2):141-155. https://doi.org/10.1159/000104348
  39. Mironenko IA. Praktikum po obshchey, eksperimental’noy i prikladnoy psikhologii. Ucheb. Posobiye. V.D. Balin, V.K. Gerbachevskiy i dr. Spb.: Izd-vo «Piter»; 2000. (In Russ.)
  40. Khersonskiy BG. Metod piktogramm v psikhodiagnostike psikhicheskikh zabolevaniy. M.: Rech’; 2003. (In Russ.)
  41. Ranganath C, Minzenberg MJ, Ragland JD. The cognitive neuroscience of memory function and dysfunction in schizophrenia. Biol Psychiatry. 2008;64(1):18-25. https://doi.org/10.1016/j.biopsych.2008.04.011
  42. Keefe RSE, Harvey PD. Cognitive impairment in schizophrenia. Handb Exp Pharmacol. 2012;213:11-37. https://doi.org/10.1007/978-3-642-25758-2_2

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.